Key customer or GPO loss
Revenue and cash flow can fall quickly if a major customer leaves or renews on less favorable terms.
- Scope
- U.S. distribution and national accounts
- Materiality
- high
Cencora, Inc.
Cencora on lääkejakeluun ja -hankintaan erikoistunut yhtiö, joka toimii lääkkeiden valmistajien ja terveydenhuollon palveluntarjoajien välissä siirtäen merkkituotteita, erikoislääkkeitä, geneerisiä lääkkeitä ja itsehoitotuotteita laajan jakeluverkoston kautta. Lisäksi se myy korkeamman arvon palveluja kaupallistamiseen, sääntelytukeen, logistiikkaan, varastonhallintaan ja apteekkitoimintaan liittyen. Yhtiö palvelee sairaaloita, apteekkeja, klinikoita, eläinlääkäreitä ja muita hoitopaikkoja Yhdysvalloissa ja valituilla kansainvälisillä markkinoilla. Sen liiketoimintamalli perustuu suurivolyymiseen jakeluun sekä palvelulisäyksiin, jotka auttavat asiakkaita parantamaan saatavuutta, tehokkuutta ja potilashoitoa.
1,1 %
3,6 %
0,5 %
+9,3 %
0.90
0.55
| % | |
|---|---|
| U.S. Healthcare Solutions distribution | 85% Wholesale distribution of pharmaceuticals and healthcare products to U.S. provider and pharmacy customers. |
| International Healthcare Solutions | 9% Pharmaceutical wholesale and related services in Europe, Canada and other select markets. |
| Global commercialization services | 3% Regulatory, market access, development consulting, pharmacovigilance and quality services for life sciences clients. |
| Specialty logistics and supply chain services | 2% Premium logistics, cold-chain and specialty transportation services for biopharma and healthcare customers. |
| Animal health distribution | 1% Veterinary pharmaceutical and related product distribution through animal health channels. |
Cencora myy ensisijaisesti terveydenhuollon palveluntarjoajille, jotka tarvitsevat luotettavaa ja usein toistuvaa lääketoimitusta ja niihin liittyviä...
- U.S. retail and specialty pharmaciesprimary
Buy branded, generic and specialty pharmaceuticals for daily dispensing and patient access.
- Hospitals and health systemsprimary
Source pharmaceuticals, specialty therapies and supply-chain services to support inpatient and outpatient care.
- Physician practices and clinicsprimary
Purchase specialty and office-administered drugs, especially for oncology, chronic care and infusion-related use.
- Pharmaceutical and biotech manufacturerssecondary
Buy logistics, regulatory, market access and commercialization services to support product launches and lifecycle management.
- International wholesale and healthcare customerssecondary
Purchase pharmaceuticals and related services in Europe, Canada and other select markets.
- Veterinary and animal health customerssecondary
Buy veterinary pharmaceuticals and related products through the animal health distribution business.
Cencora keskittyy Yhdysvaltoihin, jossa suurin osa liikevaihdosta kertyy U.S...
- •United States is the core market and the main source of revenue
- •Europe is a key international distribution and commercialization market
- •Canada is an important international healthcare solutions market
- •Foreign operations contributed about 9% of fiscal 2025 revenue
- •Currency exposure includes GBP, EUR, TRY, BRL and CAD
- •Distribution network and service centers support both U.S. and international customers
Cencoran strategiana on vahvistaa suorituskykyä ydinjakeluliiketoiminnassa samalla kun kasvatetaan korkeampikatteisia...
01
Expand and enhance the distribution networkshort-term
Capacity, service reliability and speed are critical in pharmaceutical distribution and support customer retention.
02
Invest in technology and automationmedium-term
Technology improves inventory control, pharmacy operations and operating efficiency across a high-volume supply chain.
03
Grow higher-margin manufacturer servicesmedium-term
Commercialization and consulting services can improve mix and reduce reliance on pure distribution economics.
04
Pursue disciplined acquisitionsmedium-term
Acquisitions can add scale, customer relationships and specialized capabilities, but must be integrated carefully.
Cencoran liiketoiminta on alttiina asiakaskonsentraatiolle ja sopimusuudistuksiin liittyvälle riskille, koska merkittävän asiakkaan tai...
Third-party cybersecurity incident
The company relies on suppliers, subcontractors and logistics partners to move products and provide services.
- Scope
- Supply chain and outsourced service network
- Materiality
- high
Opioid-related litigation and legal accruals
Historical prescription opioid distribution litigation can create large cash and earnings volatility.
- Scope
- U.S. legal and settlement obligations
- Materiality
- high
Foreign exchange and inflation in non-U.S. markets
International operations expose earnings to currency swings and, in Turkey, highly inflationary accounting.
- Scope
- Europe, Canada, Turkey and other non-U.S. markets
- Materiality
- medium
Goodwill and intangible asset impairment
Acquisitions and trade names create balance-sheet assets that can be written down if performance weakens.
- Scope
- Acquired businesses and reporting units
- Materiality
- high
Goodwill and intangible asset impairment
Can materially reduce operating income and net income
Working capital and cash flow timing
Affects operating cash flow and liquidity analysis
Foreign currency and highly inflationary accounting
Affects gross margin and operating results
Allowances for returns and credit losses
Affects revenue netting and bad debt expense
Litigation and uncertain tax positions
Affects provisions, liabilities and cash outflows
: 11.8.2026